id CRUZ_c605abda594616f82bfe590d97206a49
oai_identifier_str oai:www.arca.fiocruz.br:icict/9586
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Azevedo, Ana Carolina CampiEstevam, Paula de AlmeidaReis, Jordana Grazziela Alves Coelho dosMagalhães, Vanessa PeruhypeRezende, Gabriela VillelaQuaresma, Patrícia FláviaMaia, Maria de Lourdes SousaFarias, Roberto Henrique GuedesCamacho, Luiz Antonio BastosGaller, RicardoYamamura, Anna Maya YoshidaAlmeida, Luiz Fernando CarvalhoLima, Sheila Maria BarbosaNogueira, Rita Maria RibeiroSá, Gloria Regina SilvaHokama, Darcy AkemiCarvalho, Ricardo deFreire, Ricardo Aguiar VillanovaPereira Filho, EdsonLeal, Maria da Luz FernandesHomma, AkiraCarvalho, Andréa TeixeiraMartins, Reinaldo de MenezesMartins Filho, Olindo Assis2015-03-02T19:12:15Z2015-03-02T19:12:15Z2014AZEVEDO, Ana Carolina Campi et al. Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline. BMC Infectious Diseases, v. 14, p. 1-12, 2014.471-2334https://www.arca.fiocruz.br/handle/icict/958610.1186/1471-2334-14-391engBioMed CentralSubdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timelineinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro,RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Instituto de Biologia do Exército. Rio de Janeiro, RJ, Brasil.Instituto de Biologia do Exército. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.Background: The live attenuated 17DD Yellow Fever vaccine is one of the most successful prophylactic interventions for controlling disease expansion ever designed and utilized in larger scale. However, increase on worldwide vaccine demands and manufacturing restrictions urge for more detailed dose sparing studies. The establishment of complementary biomarkers in addition to PRNT and Viremia could support a secure decision-making regarding the use of 17DD YF vaccine subdoses. The present work aimed at comparing the serum chemokine and cytokine kinetics triggered by five subdoses of 17DD YF Vaccine. Methods: Neutralizing antibody titers, viremia, cytokines and chemokines were tested on blood samples obtained from eligible primary vaccinees. Results and discussion: The results demonstrated that a fifty-fold lower dose of 17DD-YF vaccine (587 IU) is able to trigger similar immunogenicity, as evidenced by significant titers of anti-YF PRNT. However, only subdoses as low as 3,013 IU elicit viremia kinetics with an early peak at five days after primary vaccination equivalent to the current dose (27,476 IU), while other subdoses show a distinct, lower in magnitude and later peak at day 6 post-vaccination. Although the subdose of 587 IU is able to trigger equivalent kinetics of IL-8/CXCL-8 and MCP-1/CCL-2, only the subdose of 3,013 IU is able to trigger similar kinetics of MIG/CXCL-9, pro-inflammatory (TNF, IFN-γ and IL-2) and modulatory cytokines (IL-5 and IL-10). Conclusions: The analysis of serum biomarkers IFN-γ and IL-10, in association to PRNT and viremia, support the recommendation of use of a ten-fold lower subdose (3,013 IU) of 17DD-YF vaccine.Yellow feverVaccineDose–responseViremiaCytokinesCkemokinesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/9586/1/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD51ORIGINAL2014_133.pdf2014_133.pdfapplication/pdf1767507https://www.arca.fiocruz.br/bitstream/icict/9586/2/2014_133.pdf7391488fb6c7b01f4d8694e5da140f58MD52TEXT2014_133.pdf.txt2014_133.pdf.txtExtracted texttext/plain43051https://www.arca.fiocruz.br/bitstream/icict/9586/3/2014_133.pdf.txtd73d5fee29dd9b209422c43a6dd27cf4MD53icict/95862023-09-14 16:02:24.29oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-14T19:02:24Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
title Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
spellingShingle Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Azevedo, Ana Carolina Campi
Yellow fever
Vaccine
Dose–response
Viremia
Cytokines
Ckemokines
title_short Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
title_full Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
title_fullStr Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
title_full_unstemmed Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
title_sort Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
author Azevedo, Ana Carolina Campi
author_facet Azevedo, Ana Carolina Campi
Estevam, Paula de Almeida
Reis, Jordana Grazziela Alves Coelho dos
Magalhães, Vanessa Peruhype
Rezende, Gabriela Villela
Quaresma, Patrícia Flávia
Maia, Maria de Lourdes Sousa
Farias, Roberto Henrique Guedes
Camacho, Luiz Antonio Bastos
Galler, Ricardo
Yamamura, Anna Maya Yoshida
Almeida, Luiz Fernando Carvalho
Lima, Sheila Maria Barbosa
Nogueira, Rita Maria Ribeiro
Sá, Gloria Regina Silva
Hokama, Darcy Akemi
Carvalho, Ricardo de
Freire, Ricardo Aguiar Villanova
Pereira Filho, Edson
Leal, Maria da Luz Fernandes
Homma, Akira
Carvalho, Andréa Teixeira
Martins, Reinaldo de Menezes
Martins Filho, Olindo Assis
author_role author
author2 Estevam, Paula de Almeida
Reis, Jordana Grazziela Alves Coelho dos
Magalhães, Vanessa Peruhype
Rezende, Gabriela Villela
Quaresma, Patrícia Flávia
Maia, Maria de Lourdes Sousa
Farias, Roberto Henrique Guedes
Camacho, Luiz Antonio Bastos
Galler, Ricardo
Yamamura, Anna Maya Yoshida
Almeida, Luiz Fernando Carvalho
Lima, Sheila Maria Barbosa
Nogueira, Rita Maria Ribeiro
Sá, Gloria Regina Silva
Hokama, Darcy Akemi
Carvalho, Ricardo de
Freire, Ricardo Aguiar Villanova
Pereira Filho, Edson
Leal, Maria da Luz Fernandes
Homma, Akira
Carvalho, Andréa Teixeira
Martins, Reinaldo de Menezes
Martins Filho, Olindo Assis
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Azevedo, Ana Carolina Campi
Estevam, Paula de Almeida
Reis, Jordana Grazziela Alves Coelho dos
Magalhães, Vanessa Peruhype
Rezende, Gabriela Villela
Quaresma, Patrícia Flávia
Maia, Maria de Lourdes Sousa
Farias, Roberto Henrique Guedes
Camacho, Luiz Antonio Bastos
Galler, Ricardo
Yamamura, Anna Maya Yoshida
Almeida, Luiz Fernando Carvalho
Lima, Sheila Maria Barbosa
Nogueira, Rita Maria Ribeiro
Sá, Gloria Regina Silva
Hokama, Darcy Akemi
Carvalho, Ricardo de
Freire, Ricardo Aguiar Villanova
Pereira Filho, Edson
Leal, Maria da Luz Fernandes
Homma, Akira
Carvalho, Andréa Teixeira
Martins, Reinaldo de Menezes
Martins Filho, Olindo Assis
dc.subject.en.pt_BR.fl_str_mv Yellow fever
Vaccine
Dose–response
Viremia
Cytokines
Ckemokines
topic Yellow fever
Vaccine
Dose–response
Viremia
Cytokines
Ckemokines
description Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, Minas Gerais, Brasil.
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2015-03-02T19:12:15Z
dc.date.available.fl_str_mv 2015-03-02T19:12:15Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv AZEVEDO, Ana Carolina Campi et al. Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline. BMC Infectious Diseases, v. 14, p. 1-12, 2014.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/9586
dc.identifier.issn.none.fl_str_mv 471-2334
dc.identifier.doi.none.fl_str_mv 10.1186/1471-2334-14-391
identifier_str_mv AZEVEDO, Ana Carolina Campi et al. Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline. BMC Infectious Diseases, v. 14, p. 1-12, 2014.
471-2334
10.1186/1471-2334-14-391
url https://www.arca.fiocruz.br/handle/icict/9586
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/9586/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/9586/2/2014_133.pdf
https://www.arca.fiocruz.br/bitstream/icict/9586/3/2014_133.pdf.txt
bitstream.checksum.fl_str_mv 7d48279ffeed55da8dfe2f8e81f3b81f
7391488fb6c7b01f4d8694e5da140f58
d73d5fee29dd9b209422c43a6dd27cf4
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009015709368320